Dang, Ha V. http://orcid.org/0000-0003-1173-9241
Cross, Robert W.
Borisevich, Viktoriya
Bornholdt, Zachary A.
West, Brandyn R. http://orcid.org/0000-0002-1399-0117
Chan, Yee-Peng
Mire, Chad E. http://orcid.org/0000-0001-7596-1808
Da Silva, Sofia Cheliout
Dimitrov, Antony S. http://orcid.org/0000-0001-8356-6701
Yan, Lianying
Amaya, Moushimi
Navaratnarajah, Chanakha K.
Zeitlin, Larry http://orcid.org/0000-0002-6857-1024
Geisbert, Thomas W. http://orcid.org/0000-0003-0858-1877
Broder, Christopher C. http://orcid.org/0000-0001-5382-0510
Veesler, David http://orcid.org/0000-0002-6019-8675
Article History
Received: 22 October 2020
Accepted: 17 March 2021
First Online: 29 April 2021
Competing interests
: Z.A.B., B.R.W. and L.Z. are employees and shareholders in Mapp Biopharmaceutical Inc., and L.Z. is a co-owner of Mapp Biopharmaceutical, Inc. D.V. is a consultant for Vir Biotechnology Inc. The Veesler laboratory has received an unrelated sponsored research agreement from Vir Biotechnology Inc. The other authors declare no competing interests.
Free to read: This content has been made available to all.